Börse:
15,250€
3,39%
Echtzeit-Aktienkurs Aerie Pharmaceuticals Inc.
Bid:
15,200€
Ask:
15,300€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 715,13 Mio. USD (46,89 Mio. x 15,250€) | |
| Website: | - | |
| Sektor: | Medizin / Biotech | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot 1 |
| dpa-AFX - | Reuters - |
| 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| KUV | - | 28,68 | 10,14 | 8,59 |
| KGV | - | - | - | - |
| Div. Rend. | - | - | - | - |
Echtzeit-Chart der Aerie Pharmaceuticals Inc. Aktie
Börsenkurse Aerie Pharmaceuticals Inc.
| Börse Frankfurt | 15,200€ | 200 | 15,300€ | 200 | 15,250€ | 3,39% |
| Euro Indikation | 15,000€ | 0 | 15,500€ | 0 | 15,250€ | 11,31% |
| Börse Stuttgart | 15,000€ | 1500 | 15,500€ | 1500 | 15,250€ | 3,74% |
| Dollar Indikation | 17,835$ | 0 | 18,490$ | 0 | 18,162$ | 2,04% |
| Lang & Schwarz | 15,100€ | 1677 | 15,300€ | 1677 | 15,200€ | 1,67% |
| Nasdaq | 17,800$ | 0 | 17,800$ | 0 | 17,800$ | 7,81% |
| Bats USA | - | 0 | - | 0 | 18,385$ | 16,32% |
| Tradegate | 15,200€ | 660 | 15,300€ | 660 | 15,250€ | 2,01% |
Fundamentaldaten der Aerie Pharmaceuticals Inc. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2020 | 83,14 Mio. | -177,86 Mio. | -183,10 Mio. | -3,99 | - | - | 8,59 |
| 2019 | 69,89 Mio. | -199,67 Mio. | -199,58 Mio. | -4,39 | - | - | 10,14 |
| 2018 | 24,18 Mio. | -232,57 Mio. | -232,57 Mio. | -5,58 | - | - | 28,68 |
| 2017 | - | -146,86 Mio. | -145,11 Mio. | -4,11 | - | - | - |
| 2016 | - | -98,87 Mio. | -99,06 Mio. | -3,40 | - | - | - |
| 2015 | - | -74,22 Mio. | -74,36 Mio. | -2,88 | - | - | - |
| 2014 | - | -48,13 Mio. | -48,13 Mio. | -2,00 | - | - | - |
| 2013 | - | -31,15 Mio. | -31,15 Mio. | -6,38 | - | - | - |
| 2012 | - | -14,98 Mio. | -14,98 Mio. | -0,70 | - | - | - |
| 2011 | - | -12,97 Mio. | -12,97 Mio. | -0,60 | - | - | - |